Trial Master File (TMF): FDA Expectations From Sponsors And Sites
WebcastFaculty
OVERVIEW
Trial Master File (TMF): FDA Expectations From Sponsors And Sites is organized by AtoZ Compliance and would be held on Aug 8, 2017.
The target audience for this medical event for Lead CRAs, CRA Managers, Project and/or Study Managers, Project and/or Clinical Trial Assistants, Clinical Operations Administrators, Quality Assurance Personnel, Sponsor and CRO personnel involved in set up, maintenance, and auditing of the Trial Master File for sponsors, Auditors engaged in the internal inspection of clinical trial documentation and practices, Consultants working in the life sciences industries responsible for assisting companies with FDA and EMA compliance for labeling content, format and management.
Key Take Away
Companies engaged in the conduct of human clinical trials must adhere to specific government regulatory requirements. Certain documents, content and images related to a clinical trial must be stored and maintained, and depending on the regulatory jurisdiction, this body of information may be stored in a trial master file (TMF).
Overview
Companies engaged in the conduct of human clinical trials must adhere to specific government regulatory requirements. Certain documents, content and images related to a clinical trial must be stored and maintained, and depending on the regulatory jurisdiction, this body of information may be stored in a trial master file (TMF).
The TMF includes all of the documentation that a sponsor must record to demonstrate that they have met their obligations for the conduct of a clinical trial.
A consolidated guidance for industry on Good Clinical Practice (GCP) in 1996 was published by the International Conference on Harmonization (ICH). The objective was to provide a unified standard for the United States, European Union, and Japan to facilitate mutual acceptance of clinical data by the regulatory authorities in these global jurisdictions.
The ICH document provided guidance for companies in all ICH regions to establish trial master files that contain key documents that enable the evaluation of the conduct of a trial and the quality of data produced uniformly by all jurisdictions involved. In the US, there is no specific requirement from FDA for companies to prepare a trial master file, but if the regulatory authority requires ICH GCP to be followed, then there is consequently a requirement to create and maintain a trial master file.
Documents contained in the TMF must be available for inspection by the appropriate regulatory authorities at any time during and after the conduct of a clinical trial, and must be submitted to support the request for product approval. This is true for pharmaceuticals, biologics and medical devices.
Why Should You Attend
You should attend this webinar if you are responsible for establishing or maintaining a TMF, or providing quality assurance for data included in the file. This webinar will also benefit those involved in the conduct of clinical trials, audit and inspection of clinical trial study data and records, and submission of filings to regulatory agencies that involve clinical trial data.
Areas Covered In This Webinar
• Trial Master File (TMF) background and rationale
• The essential documents to include in a TMF
• Organizing and maintaining a TMF
• Standard Operating Procedure required to support TMF
• Inspection of TMF records
• Q&A
Learning Objectives are:
• Learn what content is required for a TMF for a clinical trial
• Understand how the essential documents demonstrate the conduct of the regulated activities of the investigator and sponsor
• Learn how to establish and maintain a well-organized TMF, and provide quality assurance for the data included
• Understand the importance of developing an effective Standard Operating Procedure (SOP) to support TMF activities
• Learn the importance of developing a consistent system for locating TMF documents, and preparing them for study team use or regulatory inspection
• Learn about best practices and industry standards.
Additional details will be posted as soon as they are available.
The target audience for this medical event for Lead CRAs, CRA Managers, Project and/or Study Managers, Project and/or Clinical Trial Assistants, Clinical Operations Administrators, Quality Assurance Personnel, Sponsor and CRO personnel involved in set up, maintenance, and auditing of the Trial Master File for sponsors, Auditors engaged in the internal inspection of clinical trial documentation and practices, Consultants working in the life sciences industries responsible for assisting companies with FDA and EMA compliance for labeling content, format and management.
Key Take Away
Companies engaged in the conduct of human clinical trials must adhere to specific government regulatory requirements. Certain documents, content and images related to a clinical trial must be stored and maintained, and depending on the regulatory jurisdiction, this body of information may be stored in a trial master file (TMF).
Overview
Companies engaged in the conduct of human clinical trials must adhere to specific government regulatory requirements. Certain documents, content and images related to a clinical trial must be stored and maintained, and depending on the regulatory jurisdiction, this body of information may be stored in a trial master file (TMF).
The TMF includes all of the documentation that a sponsor must record to demonstrate that they have met their obligations for the conduct of a clinical trial.
A consolidated guidance for industry on Good Clinical Practice (GCP) in 1996 was published by the International Conference on Harmonization (ICH). The objective was to provide a unified standard for the United States, European Union, and Japan to facilitate mutual acceptance of clinical data by the regulatory authorities in these global jurisdictions.
The ICH document provided guidance for companies in all ICH regions to establish trial master files that contain key documents that enable the evaluation of the conduct of a trial and the quality of data produced uniformly by all jurisdictions involved. In the US, there is no specific requirement from FDA for companies to prepare a trial master file, but if the regulatory authority requires ICH GCP to be followed, then there is consequently a requirement to create and maintain a trial master file.
Documents contained in the TMF must be available for inspection by the appropriate regulatory authorities at any time during and after the conduct of a clinical trial, and must be submitted to support the request for product approval. This is true for pharmaceuticals, biologics and medical devices.
Why Should You Attend
You should attend this webinar if you are responsible for establishing or maintaining a TMF, or providing quality assurance for data included in the file. This webinar will also benefit those involved in the conduct of clinical trials, audit and inspection of clinical trial study data and records, and submission of filings to regulatory agencies that involve clinical trial data.
Areas Covered In This Webinar
• Trial Master File (TMF) background and rationale
• The essential documents to include in a TMF
• Organizing and maintaining a TMF
• Standard Operating Procedure required to support TMF
• Inspection of TMF records
• Q&A
Learning Objectives are:
• Learn what content is required for a TMF for a clinical trial
• Understand how the essential documents demonstrate the conduct of the regulated activities of the investigator and sponsor
• Learn how to establish and maintain a well-organized TMF, and provide quality assurance for the data included
• Understand the importance of developing an effective Standard Operating Procedure (SOP) to support TMF activities
• Learn the importance of developing a consistent system for locating TMF documents, and preparing them for study team use or regulatory inspection
• Learn about best practices and industry standards.
Additional details will be posted as soon as they are available.
SPECIALITIES
Research and Clinical ResearchRELATED ONLINE COURSES
Quick Links